NK Cells in Central Nervous System Disorders
Author(s) -
Aurélie Poli,
Justyna Kmiecik,
Olivia Domingues,
François Hentges,
Mathieu Bléry,
Martha Chekenya,
José Boucraut,
Jacques Zimmer
Publication year - 2013
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.1203401
Subject(s) - immune system , innate immune system , immunology , biology , innate lymphoid cell , janus kinase 3 , inflammation , autoimmunity , crosstalk , neuroprotection , acquired immune system , interleukin 12 , interleukin 21 , neuroscience , cytotoxic t cell , t cell , in vitro , biochemistry , physics , optics
NK cells are important players in immunity against pathogens and neoplasms. As a component of the innate immune system, they are one of the first effectors on sites of inflammation. Through their cytokine production capacities, NK cells participate in the development of a potent adaptive immune response. Furthermore, NK cells were found to have regulatory functions to limit and prevent autoimmunity via killing of autologous immune cells. These paradoxical functions of NK cells are reflected in CNS disorders. In this review, we discuss the phenotypes and functional features of peripheral and brain NK cells in brain tumors and infections, neurodegenerative diseases, acute vascular and traumatic damage, as well as mental disorders. We also discuss the implication of NK cells in neurotoxicity and neuroprotection following CNS pathology, as well as the crosstalk between NK cells and brain-resident immune cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom